tiprankstipranks
Trending News
More News >
Globus Medical (GMED)
NYSE:GMED
US Market

Globus Medical (GMED) Ratios

Compare
848 Followers

Globus Medical Ratios

GMED's free cash flow for Q4 2024 was $0.60. For the 2024 fiscal year, GMED's free cash flow was decreased by $ and operating cash flow was $0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.54 4.88 6.18 6.17 6.80
Quick Ratio
1.77 2.72 4.30 4.48 4.91
Cash Ratio
0.92 1.19 0.95 1.38 1.98
Solvency Ratio
0.33 0.25 1.12 1.01 0.95
Operating Cash Flow Ratio
0.61 0.62 1.12 1.97 1.65
Short-Term Operating Cash Flow Coverage
50.80 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 1.10B$ 827.25M$ 753.59M$ 648.64M$ 648.58M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.10 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.13 0.13 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
0.11 0.12 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.11 0.09 0.00 0.00 0.00
Financial Leverage Ratio
1.26 1.27 1.12 1.12 1.11
Debt Service Coverage Ratio
44.49 0.00 17.68 23.56 11.09
Interest Coverage Ratio
0.00 0.00 16.02 18.50 7.99
Debt to Market Cap
0.05 0.07 0.00 0.00 0.00
Interest Debt Per Share
3.96 4.60 0.20 0.14 0.19
Net Debt to EBITDA
-0.52 0.15 -0.47 -0.75 -1.32
Profitability Margins
Gross Profit Margin
58.90%65.05%74.22%75.03%72.44%
EBIT Margin
8.72%12.87%23.10%18.83%14.63%
EBITDA Margin
18.80%22.10%29.77%26.12%22.60%
Operating Profit Margin
6.59%8.49%22.29%17.95%14.12%
Pretax Profit Margin
4.79%10.54%23.76%18.83%15.96%
Net Profit Margin
4.09%7.83%18.59%15.57%12.96%
Continuous Operations Profit Margin
4.09%7.83%18.59%15.57%12.96%
Net Income Per EBT
85.31%74.29%78.25%82.70%81.24%
EBT Per EBIT
72.73%124.22%106.61%104.92%112.98%
Return on Assets (ROA)
1.96%2.42%9.16%7.62%6.09%
Return on Equity (ROE)
2.47%3.07%10.30%8.57%6.79%
Return on Capital Employed (ROCE)
3.78%2.84%11.89%9.46%7.15%
Return on Invested Capital (ROIC)
3.21%2.10%9.29%7.83%5.81%
Return on Tangible Assets
3.41%4.51%10.48%8.73%7.12%
Earnings Yield
0.92%2.04%2.55%2.05%1.59%
Efficiency Ratios
Receivables Turnover
4.52 3.11 4.71 5.78 5.33
Payables Turnover
13.78 9.67 7.31 10.90 11.95
Inventory Turnover
1.57 0.65 0.88 1.01 0.95
Fixed Asset Turnover
4.12 2.42 4.20 4.33 3.64
Asset Turnover
0.48 0.31 0.49 0.49 0.47
Working Capital Turnover Ratio
1.77 1.34 1.32 1.34 1.24
Cash Conversion Cycle
286.70 644.48 441.38 391.22 422.57
Days of Sales Outstanding
80.80 117.49 77.55 63.11 68.51
Days of Inventory Outstanding
232.38 564.73 413.79 361.61 384.62
Days of Payables Outstanding
26.48 37.73 49.96 33.50 30.56
Operating Cycle
313.17 682.22 491.34 424.72 453.13
Cash Flow Ratios
Operating Cash Flow Per Share
3.84 2.15 1.78 2.74 2.02
Free Cash Flow Per Share
2.99 1.46 1.04 2.18 1.37
CapEx Per Share
0.85 0.69 0.74 0.56 0.65
Free Cash Flow to Operating Cash Flow
0.78 0.68 0.59 0.79 0.68
Dividend Paid and CapEx Coverage Ratio
4.51 3.11 2.41 4.86 3.12
Capital Expenditure Coverage Ratio
4.51 3.11 2.41 4.86 3.12
Operating Cash Flow Coverage Ratio
0.97 0.47 29.69 54.68 41.41
Operating Cash Flow to Sales Ratio
0.21 0.16 0.17 0.29 0.25
Free Cash Flow Yield
3.61%2.74%1.40%3.02%2.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
109.01 49.05 39.24 48.75 62.86
Price-to-Sales (P/S) Ratio
4.46 3.84 7.30 7.59 8.15
Price-to-Book (P/B) Ratio
2.69 1.51 4.04 4.18 4.27
Price-to-Free Cash Flow (P/FCF) Ratio
27.70 36.47 71.46 33.15 47.58
Price-to-Operating Cash Flow Ratio
21.56 24.75 41.81 26.33 32.34
Price-to-Earnings Growth (PEG) Ratio
-3.60 -1.16 1.42 1.15 -1.86
Price-to-Fair Value
2.69 1.51 4.04 4.18 4.27
Enterprise Value Multiple
23.18 17.54 24.03 28.31 34.73
EV to EBITDA
23.18 17.54 24.03 28.31 34.73
EV to Sales
4.36 3.88 7.15 7.39 7.85
EV to Free Cash Flow
27.09 36.80 70.08 32.30 45.84
EV to Operating Cash Flow
21.09 24.97 41.00 25.64 31.16
Tangible Book Value Per Share
14.37 14.49 15.78 14.82 12.81
Shareholders’ Equity Per Share
30.78 35.35 18.38 17.29 15.28
Tax and Other Ratios
Effective Tax Rate
0.15 0.26 0.22 0.17 0.19
Revenue Per Share
18.56 13.87 10.18 9.51 8.00
Net Income Per Share
0.76 1.09 1.89 1.48 1.04
Tax Burden
0.85 0.74 0.78 0.83 0.81
Interest Burden
0.55 0.82 1.03 1.00 1.09
Research & Development to Revenue
0.06 0.08 0.07 0.10 0.11
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.03 0.03 0.03 0.03
Income Quality
5.06 1.98 0.94 1.85 1.94
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis